Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Similar content being viewed by others Background Diabetes mellitus (DM) is becoming increasingly prevalent in Korean adults, affecting up to 6.05 million individuals (16.7%) according to the 2021 Diabetes Fact Sheet in Korea [1]
The actual steady-state monthly cost ranges from $129 a month (oral tirzepatide, 12-month plan) up to $449 a month (tirzepatide, 1-month plan), depending entirely on which formulation and plan length you pick
In other words, potency changed the amount of weight lost, not the quality of the loss
It is that retatrutide is the one major GLP-1 with no legitimate supply anywhere, which means there is no safer tier to step down to, no approved product to wait for, no pharmacy version to choose instead
US$ 20.62
US$ 21.12
US$ 29.54
US$ 23.19
